Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Soleno Therapeutics Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +31 vs. Q2 2023
- Shares held
- 20.3M
- +15.2M (+298.2%) vs. Q2 2023
- Total value
- $598.8M
- +$577.0M (+2,645.6%) vs. Q2 2023
- New holders
- 36
- 6 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 33 | $974 | 0.00% | −7−17.5% | Reduced |
| Group One Trading, L.P. | 37 | $1.09K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 71 | $2.10K | 0.00% | −800−91.8% | Reduced |
| Citigroup Inc | 103 | $3.04K | 0.00% | +103 | New |
| VisionPoint Advisory Group, LLC | 168 | $4.96K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 253 | $7.47K | 0.00% | −89−26.0% | Reduced |
| Bollard Group LLC | 2,288 | $68.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,898 | $115.0K | 0.00% | +1,805+86.2% | Added |
| Clayton Partners LLC | 7,000 | $206.6K | 0.18% | +7,000 | New |
| Northern Trust Corp | 7,030 | $207.5K | 0.00% | +7,030 | New |
| Tower Research Capital LLC (TRC) | 7,299 | $215.4K | 0.01% | +6,568+898.5% | Added |
| Sassicaia Capital Advisers LLC | 8,655 | $255.4K | 12.02% | +8,655 | New |
| Bank of New York Mellon Corp | 9,487 | $280.0K | 0.00% | +9,487 | New |
| Captrust Financial Advisors | 10,186 | $300.6K | 0.00% | +10,186 | New |
| SEI Investments Co | 13,571 | $400.5K | 0.00% | +13,571 | New |
| State Street Corp | 15,448 | $455.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 20,754 | $612.5K | 0.00% | −4,212−16.9% | Reduced |
| Schonfeld Strategic Advisors LLC | 23,200 | $684.6K | 0.01% | +23,200 | New |
| Maven Securities LTD | 25,000 | $737.8K | 0.08% | +25,000 | New |
| Maplelane Capital, LLC | 25,000 | $737.8K | 0.08% | +25,000 | New |
| Morgan Stanley | 33,100 | $976.8K | 0.00% | +33,100 | New |
| JPMorgan Chase & Co | 33,176 | $979.0K | 0.00% | +33,170+552,833.3% | Added |
| Citadel Advisors LLC | 40,625 | $1.20M | 0.00% | +40,625 | New |
| Walleye Capital LLC | 46,244 | $1.36M | 0.02% | +46,244 | New |
| Altium Capital Management LP | 47,081 | $1.39M | 0.80% | +47,081 | New |
| Moore Capital Management, LP | 50,000 | $1.48M | 0.04% | +50,000 | New |
| Geode Capital Management, LLC | 52,553 | $1.55M | 0.00% | −2,095−3.8% | Reduced |
| Vanguard Group Inc | 55,251 | $1.63M | 0.00% | +5,312+10.6% | Added |
| Millennium Management LLC | 55,456 | $1.64M | 0.00% | +55,456 | New |
| Renaissance Technologies LLC | 61,554 | $1.82M | 0.00% | −4,500−6.8% | Reduced |
| J. Goldman & Co LP | 66,000 | $1.95M | 0.10% | −54,799−45.4% | Reduced |
| 683 Capital Management, LLC | 87,000 | $2.57M | 0.26% | +87,000 | New |
| Parkman Healthcare Partners LLC | 100,000 | $2.95M | 0.54% | +100,000 | New |
| Boothbay Fund Management, LLC | 108,377 | $3.20M | 0.11% | +108,377 | New |
| Logos Global Management LP | 125,000 | $3.69M | 0.53% | +125,000 | New |
| EAM Investors, LLC | 139,330 | $4.11M | 0.79% | +139,330 | New |
| Emerald Mutual Fund Advisers Trust | 201,326 | $5.94M | 0.36% | +201,326 | New |
| Emerald Advisers, LLC | 248,674 | $7.34M | 0.36% | +248,674 | New |
| Woodline Partners LP | 263,860 | $7.79M | 0.09% | +263,860 | New |
| Soleus Capital Management, L.P. | 325,000 | $9.59M | 0.97% | +325,000 | New |
| Silverarc Capital Management, LLC | 370,000 | $10.9M | 4.07% | +370,000 | New |
| Farallon Capital Management, L.L.C. | 388,000 | $11.4M | 0.06% | +388,000 | New |
| Nantahala Capital Management, LLC | 392,404 | $11.6M | 1.47% | −257,437−39.6% | Reduced |
| Balyasny Asset Management LLC | 458,823 | $13.5M | 0.04% | +458,823 | New |
| Frazier Life Sciences Management, L.P. | 464,937 | $13.7M | 0.91% | +464,937 | New |
| Ikarian Capital, LLC | 536,720 | $15.8M | 5.88% | +536,720 | New |
| Commodore Capital LP | 887,500 | $26.2M | 3.06% | +887,500 | New |
| Fairmount Funds Management LLC | 1,142,473 | $33.7M | 4.06% | +1,142,473 | New |
| Ra Capital Management, L.P. | 1,239,000 | $36.6M | 0.72% | +1,239,000 | New |
| Adage Capital Partners GP, L.L.C. | 1,327,000 | $39.2M | 0.09% | +1,327,000 | New |
| Janus Henderson Group PLC | 2,204,053 | $65.0M | 0.04% | +2,204,053 | New |
| Carlyle Group Inc. | 2,293,562 | $67.4M | 2.92% | +1,092,056+90.9% | Added |
| Perceptive Advisors LLC | 3,074,542 | $90.7M | 3.05% | +866,789+39.3% | Added |
| Vivo Capital, LLC | 3,203,093 | $94.5M | 11.70% | +3,203,093 | New |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −364,306−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −245,127−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −90,858−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |